向CD206+巨细胞破坏了关键抗瘤免疫轴的建立
Arja Ray1,2, Kenneth H Hu1,2, Kelly Kersten1,2
1Department of Pathology, University of California, San Francisco, CA, USA.
The Journal of experimental medicine
|November 27, 2024
概括
通常被认为是免疫抑制的CD206+巨细胞实际上通过招募CD8 T细胞和NK细胞来支持抗瘤免疫力. 它们的枯竭会损害抗瘤反应,挑战M2巨细胞分类.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 巨细胞生物学 巨细胞生物学
背景情况:
- 表达CD206的瘤相关巨细胞 (TAMs) 通常被归类为免疫抑制M2巨细胞.
- CD206+ TAMs在抗瘤免疫力中的确切作用仍然不完全理解.
研究的目的:
- 研究CD206+巨细胞和单细胞 (Mono/Macs) 在瘤微环境中的功能作用.
- 确定CD206+ Mono/Mac枯竭对免疫细胞群和抗瘤反应的影响.
主要方法:
- 开发一种新的条件CD206 (Mrc1) 敲入小鼠模型,用于特定的CD206+细胞可视化和耗尽.
- 分析免疫细胞组成,基因表达 (CXCL9,Spp1,Cxcr3,Xcl1,Flt3l) 和在CD206+ Mono/Mac耗尽后的瘤控制.
- CD206基因特征与免疫细胞特征以及人类癌症患者存活率的相关性.
主要成果:
- 早期CD206+ Mono/Macs的耗尽导致瘤中cDC1,CD8 T细胞和NK细胞的间接损失.
- CD206+ TAMs表达了CXCL9,吸引了CD8 T细胞,而耗尽的瘤显示Cxcr3和Xcl1表达减少.
- 人类癌症中的CD206复制基因特征与CD8 T细胞,cDC1和NK细胞特征以及更好的生存率相关.
结论:
- CD206+巨细胞并不均地抑制免疫力,在编排抗瘤免疫力方面发挥着至关重要的作用.
- 破坏CD206+TAM介导轴会损害T细胞依赖的瘤控制.
- 这些发现需要重新评估CD206+巨细胞在癌症免疫学中的分类.
相关概念视频
01:27Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Cytotoxic T Cells-mediated Immune Response
849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849